REPLIGEN UK LIMITED

14287620
Active Altrincham

Other manufacturing n.e.c.

19 employees website.com
Life sciences and medical technology Other manufacturing n.e.c.
R

REPLIGEN UK LIMITED

14287620

Other manufacturing n.e.c.

Founded 10 Aug 2022 Active Altrincham, United Kingdom 19 employees website.com
Life sciences and medical technology Other manufacturing n.e.c.
Accounts Submitted 22 Dec 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 3 Sept 2025 Next due 23 Aug 2026 2 months remaining
Net assets £509K £328K 2024 year on year
Total assets £1M £269K 2024 year on year
Total Liabilities £540K £59K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom

Website

www.example.com

Full company profile for REPLIGEN UK LIMITED (14287620), an active life sciences and medical technology company based in Altrincham, United Kingdom. Incorporated 10 Aug 2022. Other manufacturing n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2023–2024)

Cash in Bank

£658.65k

Increased by £158.39k (+32%)

Net Assets

£508.63k

Increased by £327.91k (+181%)

Total Liabilities

£540.30k

Decreased by £58.79k (-10%)

Turnover

£3.81M

Increased by £394.25k (+12%)

Employees

19

Increased by 1 (+6%)

Debt Ratio

52%

Decreased by 25 (-32%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Mark JacksonDirectorBritishUnited Kingdom6010 Aug 2022Active
Oakwood Corporate Secretary LimitedCorporate-secretaryUnited KingdomUnknown10 Aug 2022Active

Shareholders

Shareholders (1)

Repligen Corporation
NaN%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Mark Jackson

British

Active
Notified 1 Nov 2023
Residence United Kingdom
DOB March 1966
Nature of Control
  • Right To Appoint And Remove Directors

Repligen Corporation

United States Of America

Active
Notified 10 Aug 2022
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

REPLIGEN UK LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Dec 2025AccountsAnnual accounts made up to 31 Dec 2024
3 Sept 2025Confirmation StatementConfirmation statement made on 9 Aug 2025 with no updates
27 Aug 2024Confirmation StatementConfirmation statement made on 9 Aug 2024 with no updates
15 Aug 2024AccountsAnnual accounts made up to 31 Dec 2023
10 May 2024Persons With Significant ControlCessation of Mark Jackson as a person with significant control on 27 Nov 2023
22 Dec 2025 Accounts

Annual accounts made up to 31 Dec 2024

3 Sept 2025 Confirmation Statement

Confirmation statement made on 9 Aug 2025 with no updates

27 Aug 2024 Confirmation Statement

Confirmation statement made on 9 Aug 2024 with no updates

15 Aug 2024 Accounts

Annual accounts made up to 31 Dec 2023

10 May 2024 Persons With Significant Control

Cessation of Mark Jackson as a person with significant control on 27 Nov 2023

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

5 months ago on 22 Dec 2025

Confirmation statement made on 9 Aug 2025 with no updates

9 months ago on 3 Sept 2025

Confirmation statement made on 9 Aug 2024 with no updates

1 years ago on 27 Aug 2024

Annual accounts made up to 31 Dec 2023

1 years ago on 15 Aug 2024

Cessation of Mark Jackson as a person with significant control on 27 Nov 2023

2 years ago on 10 May 2024